Tenax Therapeutics (TENX) Net Shares Issued and Repurchased (2013 - 2026)

Tenax Therapeutics has disclosed Net Shares Issued and Repurchased across 11 years of filings, most recently posting $1.3 million for Q1 2026.

• In Q1 2026, Net Shares Issued and Repurchased changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $3.5 million, up 11.65% from the prior year.
• Net Shares Issued and Repurchased came in at $1.3 million for Q1 2026 at Tenax Therapeutics, down from $3.5 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $3.5 million in Q4 2025 to a low of $33.0 in Q4 2023.
• Average Net Shares Issued and Repurchased over 4 years is $2.0 million, with a median of $2.2 million recorded in 2024.
• Year-over-year, Net Shares Issued and Repurchased soared 9472003.03% in 2024 and climbed 11.65% in 2025.
• Over 4 years, Net Shares Issued and Repurchased stood at $33.0 in 2023, then soared by 9472003.03% to $3.1 million in 2024, then gained by 11.65% to $3.5 million in 2025, then sank by 63.8% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.1 million in Q4 2024.